Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...
Morning Overview on MSN
A cluster of heart, kidney and metabolic problems may quietly raise your cancer risk
People living with overlapping heart disease, kidney dysfunction and metabolic disorders such as obesity or diabetes face a ...
Despite an increased risk of obesity, Māori and Pasifika who have accessed GLP-1 weight loss drugs like Wegovy are a small ...
Fatty pancreas: A silent but progressive disease; know its symptoms, causes, treatment plan and more
It is possible you are wondering what the disease is all about since a lot of people just know about fatty pancreas. To know ...
AROUND 170,000 people could die from heart problems linked to obesity by 2035, a charity has warned. If current trends in ...
New data shows obesity rising fastest among the young and the poor, while it’s mainly the better off who are seeing the ...
India’s GLP-1 gold rush is fading as generic semaglutide sales slow, inventories pile up and patients quit over side effects, ...
Orthopaedic specialists say joint and back problems are rising among younger working men. Long sitting hours, poor posture ...
However, there is roughly a one in ten chance that anyone taking a GLP-1 will turn out to be a non-responder, like Janet. A ...
During Alzheimer’s and Brain Awareness Month in June, extension experts encourage Arkansans to watch for warning signs of the ...
Even as health care issues rise in the 2026 campaign debate, new data show that far more House Republicans than Democrats ...
In modern marketing, increases in activity metrics, such as clicks, leads, and reach, are often treated as indicators of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results